Barton P.  Bandy net worth and biography

Barton Bandy Biography and Net Worth

Mr. Bandy brings extensive leadership experience in health care, specifically in the bariatric and minimally invasive surgery segments. Most recently, Mr. Bandy was President and Chief Executive officer of BroadSpot Imaging Corporation, a privately held ophthalmic imaging company, and prior to that he was President of the Wellness Division at Alphaeon Corporation. He previously spent 10 years as the senior executive leading the Inamed and Allergan Health Divisions through the launch, growth and transition of LAP-BAND®. Mr. Bandy formerly held positions of increased responsibility in sales, marketing and professional education at Ethicon Endo-Surgery and Karl Storz Endoscopy, America.

What is Barton P. Bandy's net worth?

The estimated net worth of Barton P. Bandy is at least $2,851.01 as of August 5th, 2022. Mr. Bandy owns 15,461 shares of ReShape Lifesciences stock worth more than $2,851 as of March 29th. This net worth evaluation does not reflect any other assets that Mr. Bandy may own. Learn More about Barton P. Bandy's net worth.

How do I contact Barton P. Bandy?

The corporate mailing address for Mr. Bandy and other ReShape Lifesciences executives is 1001 Calle Amanecer, San Clemente CA, 92673. ReShape Lifesciences can also be reached via phone at (949) 429-6680 and via email at [email protected]. Learn More on Barton P. Bandy's contact information.

Has Barton P. Bandy been buying or selling shares of ReShape Lifesciences?

Barton P. Bandy has not been actively trading shares of ReShape Lifesciences within the last three months. Most recently, Barton P. Bandy sold 233 shares of the business's stock in a transaction on Friday, August 5th. The shares were sold at an average price of $23.50, for a transaction totalling $5,475.50. Following the completion of the sale, the chief executive officer now directly owns 15,461 shares of the company's stock, valued at $363,333.50. Learn More on Barton P. Bandy's trading history.

Who are ReShape Lifesciences' active insiders?

ReShape Lifesciences' insider roster includes Barton Bandy (CEO), Dan Gladney (Director), and Thomas Stankovich (CFO). Learn More on ReShape Lifesciences' active insiders.

Are insiders buying or selling shares of ReShape Lifesciences?

In the last year, ReShape Lifesciences insiders bought shares 1 times. They purchased a total of 17,702 shares worth more than $26,907.04. In the last year, insiders at the medical device company sold shares 9 times. They sold a total of 844 shares worth more than $1,288.44. The most recent insider tranaction occured on October, 25th when CFO Thomas Stankovich sold 131 shares worth more than $35.37. Insiders at ReShape Lifesciences own 0.1% of the company. Learn More about insider trades at ReShape Lifesciences.

Information on this page was last updated on 10/25/2023.

Barton P. Bandy Insider Trading History at ReShape Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/5/2022Sell233$23.50$5,475.5015,461View SEC Filing Icon  
7/1/2022Sell228$27.50$6,270.0015,695View SEC Filing Icon  
6/1/2022Sell226$47.50$10,735.0015,924View SEC Filing Icon  
4/1/2022Sell221$56.50$12,486.5016,378View SEC Filing Icon  
1/31/2022Sell166$61.00$10,126.00View SEC Filing Icon  
1/4/2022Sell143$89.50$12,798.50View SEC Filing Icon  
12/2/2021Sell268$91.50$24,522.00View SEC Filing Icon  
11/2/2021Sell270$134.50$36,315.00View SEC Filing Icon  
10/1/2021Sell251$138.50$34,763.50View SEC Filing Icon  
9/10/2021Sell5,889$144.50$850,960.5019,202View SEC Filing Icon  
See Full Table

Barton P. Bandy Buying and Selling Activity at ReShape Lifesciences

This chart shows Barton P Bandy's buying and selling at ReShape Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReShape Lifesciences Company Overview

ReShape Lifesciences logo
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Read More

Today's Range

Now: $0.18
Low: $0.18
High: $0.20

50 Day Range

MA: $0.18
Low: $0.15
High: $0.23

2 Week Range

Now: $0.18
Low: $0.14
High: $4.10

Volume

755,418 shs

Average Volume

866,259 shs

Market Capitalization

$2.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19